Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition

NCT01722201 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Fasting

Interventions

DRUG: Risperidone Tablet 1 mg
DRUG: Risperidone

Sponsor

IPCA Laboratories Ltd.